2019, Number 05
<< Back Next >>
Ginecol Obstet Mex 2019; 87 (05)
Treatment of breast cancer in pregnant women: clinical case
Montaño-Serrano M, Rojo-Novo S, Albalat-Fernández R, Novo-Cabrera J, La Calle-Marcos M
Language: Spanish
References: 22
Page: 324-333
PDF size: 381.72 Kb.
ABSTRACT
Background: Breast cancer is the most prevalent cancer nowadays and is the most
common at the pregnancy and postpartum period. The incidence is between 0.2-2.6%
and is currently increasing due to delayed childbearing. The treatment implies a challenge
for the health systems because the welfare of the mother and her child must be
valued and safeguarded.
Clinical case: A 26-year-old patient who attended the consultation for right mastalgia,
with rapid growth from the beginning of pregnancy. During the mammary examination,
a hard consistency tumor of 8 cm was observed, occupying both upper quadrants of
the right breast, with reddening of the skin. The ultrasound revealed a heterogeneous
solid-cystic tumor, 8 x 5 cm, without pathological axillary lymph nodes. The anatomopathological
study of the biopsy reported an infiltrating carcinoma, with triple negative
immunophenotype (negative immunoreactivity for estrogen and progesterone receptors,
and Her-2 with Ki67 proliferation index of 80%), which confirmed the diagnosis of
breast cancer locally advanced in the second trimester of pregnancy. After administration
of three cycles of neoadjuvant chemotherapy with anthracyclines (doxorubicin and
cyclophosphamide) trisemanales, termination of pregnancy was indicated by induction
of labor at week 36 + 6. A male was born at 2800 g, with Apgar 9-10- 10 The mother
and her son evolved satisfactorily, so they were discharged 4 days after the intervention.
Ten months after mastectomy, she enjoys good physical and psycho-logical health, as
does her 15-month-old son. Continues in close monitoring in the Oncology service.
Conclusions: The treatment of breast cancer during pregnancy is safe and offers
good long-term results. The important intervention and multidisciplinary assessment,
in addition to the correct advice and psychological support to the family.
REFERENCES
Álvarez-Tapias C, et al. Actualización del manejo clínico del cáncer mamario asociado al embarazo. Revisión de la Literatura. Rev Colomb Salud Libre 2017;(2):50-59. http:// doi.org/10.1016/j.rccan.2017.02.018
Shim M, et al. Clinical characteristics and outcome of cancer diagnosed during pregnancy. Obstet Gynecol Sci. 2016;59(1):1-8. http://doi.org/10.5468/ogs.2016.59.1.1
Shlensky V, et al. Management of Breast Cancer during Pregnancy: Are We Compliant with Current Guidelines?. Am J Perinatol Rep. 2017;7(1):39-43. http://doi. org/10.1055/s-0037-1599133
Sule E, et al. Management of pregnancy associated breast cancer with chemotherapy in a developing country. Int J Surg Case Rep 2015;17:117-120. http://doi.org/10.1016/j. ijscr.2015.10.008
Albalat-Fernández R, et al. Biopsia selectiva de ganglio centinela en mujer embarazada con cáncer de mama. Prog Obstet Ginecol. 2015;58(6):283-286. http://doi. org/10.1016/j.pog.2015.02.008
Hernández-Blanquisett A, et al. Breast cancer in pregnancy: an institutional experience. Ecancermedicalscience. 2015;9:551. http://doi.org/10.3332/ecancer.2015.551
Rovera F, et al. Breast cancer in pregnancy. Breast J 2010;16(Suppl 1):S22-5. http://doi.org/10.1111/j.1524- 4741.2010.00998.x
Simonescu A, et al. Advanced metastatic breast cancer in pregnancy: the imperative of physical breast examination in pregnancy. Rom J Morphol Embryol 2017;58(2):645-650. http:// www.rjme.ro/RJME/resources/files/580217645650.pdf
Upadhayay R, et al. Triple negative breast cancer in pregnancy and postpartum: two case reports in hispanic women. Case Rep Obstet Gynecol 2015;2015:856931. http:// doi.org/10.1155/2015/856931
Zagouri F, et al. Cancer in pregnancy: disentangling treatment modalities. ESMO Open. 2016;1(3):e000016. http://doi.org/10.1136/esmoopen-2015-000016
Ye X, et al. Study on the adverse effects following chemotherapy for breast cancer diagnosis during pregnancy. Medicine 2017;96(46):e8582. http://doi.org/10.1097/ MD.0000000000008582
Nargotra N, et al. Pregnancy associated breast cancer: awareness is the key to diagnosis-a case report. J Clin Diagn Res 2015;9(11):9-11. http://doi.org/10.7860/ JCDR/2015/15022.6832
International Commission on Radiological Protection. Pregnancy and medical radiation. Ann ICRP 2000;30(1):iii-viii, 1-43.
DeSantis CE, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64(4):252-71. http:// doi.org/10.3322/caac.21235
Amant F, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. The Lancet Oncology, 2012; 13(3):256-264. http://doi.org/10.1016/ S1470-2045(11)70363-1
Litton JK, et al. Breast cancer and pregnancy: current concepts in diagnosis and treatment. Oncologist 2010;15(12):1238- 47. http://doi.org/10.1634/theoncologist.2010-0262
Peccatori F, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;(Suppl 6):160-70. http://doi. org/10.1093/annonc/mdt199
Calsteren KV, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer 2010;20:1456-64. http://doi. org/10.1111/IGC.0b013e3181fb18c8
Loibl S, et al. Treatment of breast cancer during pregnancy: an observational study. The Lancet Oncology 2012;13(9):887- 896. http://doi.org/10.1016/S1470-2045(12)70261-9
Zagouri F, et al. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat 2013;137:349-57. http://doi.org/10.1007/ s10549-012-2368-y
Amant F, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 2013;31(20):2532- 2539. http://doi.org/10.1200/JCO.2012.45.6335
Gentilini O, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348-51. http://doi.org/10.1093/annonc/mdh355